| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 8e-05 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |